Deliver An Omnichannel Experience With Medical Affairs Global Content Strategies

Reach your audience faster in a conceptually equivalent, culturally appropriate and compliant way.

Learn more
Healthcare global with hand reaching out to connect

Customer-centric focus to effectively engage and educate key stakeholders, no matter the language

Increasingly specialty medicine requires increasingly specialized education. The methods to deliver digital content are multiplying. The way physicians consume medical content is evolving. All of the above create complexity for medical affairs teams trying to deliver high-quality, engaging content.

With 30+ years of experience, TransPerfect Life Sciences helps MedAffairs teams adapt their communications to effectively reach patients, sponsors, CROs, HCPs, and the general public in compliance with local regulations.

patient engagement in clinical R&D

Evolve Your Medical Affairs Operations From a Regional to a Global Integrated Model

With our expert localization and content adaption service for medical affairs teams, we have helped them see a reduction in content development costs by over 25%.

Why Choose TransPerfect Life Sciences for your Medical Affairs Content Creation and Adaption?

  • >25% Reduction in Content Development Costs
  • Future-Proof Scalability with Technology Driven Workflows and Integrations
  • Flexible and Customizable
  • Fully Integrated Model With Knowledge Management Systems and Processes

Even simple changes to the language of medical affairs content can significantly impact the effectiveness of global messaging.

We make sure your communications relay exactly what you mean, regardless of who you’re speaking to.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects today’s eCOA capabilities or institutional habit. Paper is often framed as the “gold standard,” yet paper-based patient-reported outcome data can be incomplete, error-prone and difficult to ...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...

C3 Summit 2026 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

Interested in learning how we can help your Medical Affairs content strategies?